Full history for every metric is available with a Kvantra account
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 117 | 133 | 164 | 149 | 155 | 120 | 132 | 132 |
| Operating profit | $m | -1.87 | -1.72 | ||||||
| Net profit | $m | -5.8 | -8.1 | -3.2 | -21.1 | -4.2 | 10.2 | -1.3 | -1.3 |
| EPS reported | $ | -17.21 | -233.1 | ||||||
| Operating cashflow per share | $ | -19.18 | -1.57 | ||||||
| Capex per share | $ | 0.01 | 0.00 | ||||||
| FCF per share | $ | -19.19 | -1.57 | ||||||
| Free cash flow | $m | -1.39 | -1.39 | ||||||
| Net debt | $m | -17.9 | -17.9 | ||||||
| Book value equity | $m | 40.8 | 40.8 | ||||||
| Book value per share | $ | 561.2 | 45.96 | ||||||
| Number of shares | m | 0.07 | 0.89 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.01 | 0.02 | ||||||
| P/S LTM | x | 0.00 | 0.01 | ||||||
| P/FCF LTM | x | -0.25 | -0.73 | ||||||
| EV/EBITDA LTM | x | 11.67 | 11.23 | ||||||
| EV/Sales LTM | x | -0.13 | -0.13 | ||||||
| Earnings Yield LTM | % | -351.91% | -124.72% | ||||||
| FCF Yield | % | -392.42% | -137.28% | ||||||
| Quality | |||||||||
| ROE | % | -3.07% | -3.54% | ||||||
| ROIC | % | -4.20% | -3.87% | ||||||
| Operating margin | % | -1.41% | -1.30% | ||||||
| Gross margin | % | 3.60% | 3.60% | ||||||
| FCF/Sales | % | -1.06% | -1.06% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +10.16% | +10.16% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | 0.00% | 0.00% | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -61.51 | -61.51 | ||||||
| Net Debt/EBITDA | x | 11.91 | 11.91 | ||||||
| EBIT/Net interest | x | -27.82 | -25.61 | ||||||
| Net debt/market cap | % | - | -1761.3% | ||||||
| Net debt/Equity | x | -0.44 | -0.44 | ||||||
| Gross debt/equity | x | 0.00 | 0.00 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free